Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9008466a40998f8be8e54cd3aceb10a2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b203814aca042c080311fe6e08bd76c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768632123315480ebd5a7524cbbe5ffa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf18d31e3b626414080bc578f76a961 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43b7a9a5ff8af60459f655af3f3a3709 |
publicationDate |
2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2629085-C2 |
titleOfInvention |
Crystalline micro particles of beta-agonist, coated with fatty acid |
abstract |
FIELD: chemistry. n SUBSTANCE: crystalline microparticles consisting of formoterol or its pharmaceutically acceptable salts and myristic acid in amount of 1.0 to 2.0% by weight are described. Myristic acid forms continuous film on surface of microparticles. Crystalline microparticles are used in production of pharmaceutical aerosol compositions in the form of suspension in liquefied propellant gas or in the form of powder compositions. Method of producing microparticles and metered-dose inhaler under pressure filled with aerosol composition has been also described. Crystalline microparticles are used for prevention and/or treatment of respiratory disease, such as asthma or chronic obstructive pulmonary disease. n EFFECT: crystalline microparticles of the invention are characterized by improved stability and composition of such particles with improved aerosol characteristics. n 9 cl, 1 dwg, 4 tbl, 6 ex |
priorityDate |
2011-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |